Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -53,020 | -64,790 | -59,013 | -60,535 | -75,985 |
| Depreciation Amortization | 18,486 | 17,668 | 24,951 | 18,896 | 18,216 |
| Accounts receivable | -7,628 | -2,075 | -1,788 | -554 | 10,521 |
| Accounts payable and accrued liabilities | 3,356 | 787 | -294 | 585 | -2,271 |
| Other Working Capital | 2,414 | -13,597 | -3,568 | 8,770 | 4,712 |
| Other Operating Activity | 20,975 | 26,797 | 14,511 | 8,740 | 5,669 |
| Operating Cash Flow | $-15,417 | $-35,210 | $-25,201 | $-24,098 | $-39,138 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -12,717 | -2,531 | -372 | -1,566 | -5,065 |
| Net Acquisitions | 15,882 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | N/A | -62,370 | -1,450 | -6,276 | -38,594 |
| Sale Of Investment | 36,810 | 25,600 | 6,541 | 25,550 | 88,761 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -50 | N/A |
| Other Investing Activity | 0 | 0 | 0 | -50 | 0 |
| Investing Cash Flow | $39,975 | $-39,301 | $4,719 | $17,658 | $45,102 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 55,000 | N/A | N/A | N/A |
| Debt Repayment | N/A | -51,826 | -2,862 | 0 | N/A |
| Common Stock Issued | 22,000 | 2,133 | 60,880 | 29,115 | 227 |
| Other Financing Activity | -1,143 | -2,517 | -358 | -118 | -111 |
| Financing Cash Flow | $20,857 | $2,790 | $57,660 | $28,997 | $116 |
| Exchange Rate Effect | 385 | 56 | 167 | 454 | -152 |
| Beginning Cash Position | 23,736 | 95,401 | 58,056 | 35,045 | 29,117 |
| End Cash Position | 69,536 | 23,736 | 95,401 | 58,056 | 35,045 |
| Net Cash Flow | $45,800 | $-71,665 | $37,345 | $23,011 | $5,928 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,417 | -35,210 | -25,201 | -24,098 | -39,138 |
| Capital Expenditure | -12,717 | -2,531 | -372 | -1,566 | -5,065 |
| Free Cash Flow | -28,134 | -37,741 | -25,573 | -25,664 | -44,203 |